Figure 4
From: In vivo assessment of increased oxidation of branched-chain amino acids in glioblastoma
Ex vivo assay of (a) BCAT and BCKDC activities in brain tissues. (b) Protein expression levels, normalized to the protein expression in the contralateral normal-appearing brain (NAB), of BCAT1, BCAT2 and BCKDC-E1α (Western blot analysis, *p < 0.05, **p < 0.01).
